nodes	percent_of_prediction	percent_of_DWPC	metapath
Varenicline—Infestation—Capecitabine—colon cancer	0.00167	0.00167	CcSEcCtD
Varenicline—Depression—Capecitabine—colon cancer	0.00167	0.00167	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00166	0.00166	CcSEcCtD
Varenicline—Acute coronary syndrome—Capecitabine—colon cancer	0.00165	0.00165	CcSEcCtD
Varenicline—Lethargy—Methotrexate—colon cancer	0.00165	0.00165	CcSEcCtD
Varenicline—Cerebrovascular accident—Methotrexate—colon cancer	0.00165	0.00165	CcSEcCtD
Varenicline—Discomfort—Irinotecan—colon cancer	0.00164	0.00164	CcSEcCtD
Varenicline—Myocardial infarction—Capecitabine—colon cancer	0.00164	0.00164	CcSEcCtD
Varenicline—Oedema—Vincristine—colon cancer	0.00163	0.00163	CcSEcCtD
Varenicline—Stomatitis—Capecitabine—colon cancer	0.00163	0.00163	CcSEcCtD
Varenicline—Infection—Vincristine—colon cancer	0.00162	0.00162	CcSEcCtD
Varenicline—Conjunctivitis—Capecitabine—colon cancer	0.00162	0.00162	CcSEcCtD
Varenicline—Convulsion—Fluorouracil—colon cancer	0.00162	0.00162	CcSEcCtD
Varenicline—Osteoarthritis—Methotrexate—colon cancer	0.00161	0.00161	CcSEcCtD
Varenicline—Nervous system disorder—Vincristine—colon cancer	0.0016	0.0016	CcSEcCtD
Varenicline—Thrombocytopenia—Vincristine—colon cancer	0.0016	0.0016	CcSEcCtD
Varenicline—Oedema—Irinotecan—colon cancer	0.00159	0.00159	CcSEcCtD
Varenicline—Chest pain—Fluorouracil—colon cancer	0.00159	0.00159	CcSEcCtD
Varenicline—Myalgia—Fluorouracil—colon cancer	0.00159	0.00159	CcSEcCtD
Varenicline—Infection—Irinotecan—colon cancer	0.00158	0.00158	CcSEcCtD
Varenicline—Hyperhidrosis—Vincristine—colon cancer	0.00158	0.00158	CcSEcCtD
Varenicline—Hepatobiliary disease—Capecitabine—colon cancer	0.00158	0.00158	CcSEcCtD
Varenicline—Epistaxis—Capecitabine—colon cancer	0.00158	0.00158	CcSEcCtD
Varenicline—Discomfort—Fluorouracil—colon cancer	0.00157	0.00157	CcSEcCtD
Varenicline—Shock—Irinotecan—colon cancer	0.00157	0.00157	CcSEcCtD
Varenicline—Nervous system disorder—Irinotecan—colon cancer	0.00156	0.00156	CcSEcCtD
Varenicline—Thrombocytopenia—Irinotecan—colon cancer	0.00156	0.00156	CcSEcCtD
Varenicline—Anorexia—Vincristine—colon cancer	0.00156	0.00156	CcSEcCtD
Varenicline—Irritability—Methotrexate—colon cancer	0.00154	0.00154	CcSEcCtD
Varenicline—Hyperhidrosis—Irinotecan—colon cancer	0.00154	0.00154	CcSEcCtD
Varenicline—Mood swings—Methotrexate—colon cancer	0.00153	0.00153	CcSEcCtD
Varenicline—Hypotension—Vincristine—colon cancer	0.00153	0.00153	CcSEcCtD
Varenicline—Bradycardia—Capecitabine—colon cancer	0.00153	0.00153	CcSEcCtD
Varenicline—Oedema—Fluorouracil—colon cancer	0.00152	0.00152	CcSEcCtD
Varenicline—Anorexia—Irinotecan—colon cancer	0.00152	0.00152	CcSEcCtD
Varenicline—Infection—Fluorouracil—colon cancer	0.00151	0.00151	CcSEcCtD
Varenicline—Nervous system disorder—Fluorouracil—colon cancer	0.0015	0.0015	CcSEcCtD
Varenicline—Thrombocytopenia—Fluorouracil—colon cancer	0.00149	0.00149	CcSEcCtD
Varenicline—Hypoaesthesia—Capecitabine—colon cancer	0.00149	0.00149	CcSEcCtD
Varenicline—Liver function test abnormal—Methotrexate—colon cancer	0.00149	0.00149	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Vincristine—colon cancer	0.00149	0.00149	CcSEcCtD
Varenicline—Tachycardia—Fluorouracil—colon cancer	0.00149	0.00149	CcSEcCtD
Varenicline—Hypotension—Irinotecan—colon cancer	0.00149	0.00149	CcSEcCtD
Varenicline—Urinary tract disorder—Capecitabine—colon cancer	0.00148	0.00148	CcSEcCtD
Varenicline—Insomnia—Vincristine—colon cancer	0.00148	0.00148	CcSEcCtD
Varenicline—Oedema peripheral—Capecitabine—colon cancer	0.00148	0.00148	CcSEcCtD
Varenicline—Connective tissue disorder—Capecitabine—colon cancer	0.00147	0.00147	CcSEcCtD
Varenicline—Urethral disorder—Capecitabine—colon cancer	0.00147	0.00147	CcSEcCtD
Varenicline—Breast disorder—Methotrexate—colon cancer	0.00146	0.00146	CcSEcCtD
Varenicline—Anorexia—Fluorouracil—colon cancer	0.00145	0.00145	CcSEcCtD
Varenicline—Visual impairment—Capecitabine—colon cancer	0.00145	0.00145	CcSEcCtD
Varenicline—Insomnia—Irinotecan—colon cancer	0.00144	0.00144	CcSEcCtD
Varenicline—Hypotension—Fluorouracil—colon cancer	0.00142	0.00142	CcSEcCtD
Varenicline—Decreased appetite—Vincristine—colon cancer	0.00142	0.00142	CcSEcCtD
Varenicline—Dyspnoea—Irinotecan—colon cancer	0.00142	0.00142	CcSEcCtD
Varenicline—Erythema multiforme—Capecitabine—colon cancer	0.00142	0.00142	CcSEcCtD
Varenicline—Somnolence—Irinotecan—colon cancer	0.00142	0.00142	CcSEcCtD
Varenicline—Gastrointestinal disorder—Vincristine—colon cancer	0.00141	0.00141	CcSEcCtD
Varenicline—Fatigue—Vincristine—colon cancer	0.00141	0.00141	CcSEcCtD
Varenicline—Eye disorder—Capecitabine—colon cancer	0.0014	0.0014	CcSEcCtD
Varenicline—Dyspepsia—Irinotecan—colon cancer	0.0014	0.0014	CcSEcCtD
Varenicline—Tinnitus—Capecitabine—colon cancer	0.0014	0.0014	CcSEcCtD
Varenicline—Pain—Vincristine—colon cancer	0.0014	0.0014	CcSEcCtD
Varenicline—Constipation—Vincristine—colon cancer	0.0014	0.0014	CcSEcCtD
Varenicline—Asthma—Methotrexate—colon cancer	0.00139	0.00139	CcSEcCtD
Varenicline—Cardiac disorder—Capecitabine—colon cancer	0.00139	0.00139	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00139	0.00139	CcSEcCtD
Varenicline—Decreased appetite—Irinotecan—colon cancer	0.00138	0.00138	CcSEcCtD
Varenicline—Insomnia—Fluorouracil—colon cancer	0.00138	0.00138	CcSEcCtD
Varenicline—Gastrointestinal disorder—Irinotecan—colon cancer	0.00137	0.00137	CcSEcCtD
Varenicline—Fatigue—Irinotecan—colon cancer	0.00137	0.00137	CcSEcCtD
Varenicline—Pain—Irinotecan—colon cancer	0.00136	0.00136	CcSEcCtD
Varenicline—Constipation—Irinotecan—colon cancer	0.00136	0.00136	CcSEcCtD
Varenicline—Angiopathy—Capecitabine—colon cancer	0.00136	0.00136	CcSEcCtD
Varenicline—Dyspnoea—Fluorouracil—colon cancer	0.00136	0.00136	CcSEcCtD
Varenicline—Somnolence—Fluorouracil—colon cancer	0.00136	0.00136	CcSEcCtD
Varenicline—Immune system disorder—Capecitabine—colon cancer	0.00135	0.00135	CcSEcCtD
Varenicline—Mediastinal disorder—Capecitabine—colon cancer	0.00135	0.00135	CcSEcCtD
Varenicline—Chills—Capecitabine—colon cancer	0.00135	0.00135	CcSEcCtD
Varenicline—Dyspepsia—Fluorouracil—colon cancer	0.00134	0.00134	CcSEcCtD
Varenicline—Arrhythmia—Capecitabine—colon cancer	0.00134	0.00134	CcSEcCtD
Varenicline—Abdominal discomfort—Methotrexate—colon cancer	0.00134	0.00134	CcSEcCtD
Varenicline—Gastrointestinal pain—Vincristine—colon cancer	0.00134	0.00134	CcSEcCtD
Varenicline—Decreased appetite—Fluorouracil—colon cancer	0.00133	0.00133	CcSEcCtD
Varenicline—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00132	0.00132	CcSEcCtD
Varenicline—Mental disorder—Capecitabine—colon cancer	0.00131	0.00131	CcSEcCtD
Varenicline—Feeling abnormal—Irinotecan—colon cancer	0.00131	0.00131	CcSEcCtD
Varenicline—Erythema—Capecitabine—colon cancer	0.00131	0.00131	CcSEcCtD
Varenicline—Malnutrition—Capecitabine—colon cancer	0.00131	0.00131	CcSEcCtD
Varenicline—Pain—Fluorouracil—colon cancer	0.0013	0.0013	CcSEcCtD
Varenicline—Gastrointestinal pain—Irinotecan—colon cancer	0.0013	0.0013	CcSEcCtD
Varenicline—Body temperature increased—Vincristine—colon cancer	0.00129	0.00129	CcSEcCtD
Varenicline—Abdominal pain—Vincristine—colon cancer	0.00129	0.00129	CcSEcCtD
Varenicline—Flatulence—Capecitabine—colon cancer	0.00129	0.00129	CcSEcCtD
Varenicline—Erectile dysfunction—Methotrexate—colon cancer	0.00128	0.00128	CcSEcCtD
Varenicline—Dysgeusia—Capecitabine—colon cancer	0.00128	0.00128	CcSEcCtD
Varenicline—Photosensitivity reaction—Methotrexate—colon cancer	0.00127	0.00127	CcSEcCtD
Varenicline—Back pain—Capecitabine—colon cancer	0.00126	0.00126	CcSEcCtD
Varenicline—Abdominal pain—Irinotecan—colon cancer	0.00126	0.00126	CcSEcCtD
Varenicline—Body temperature increased—Irinotecan—colon cancer	0.00126	0.00126	CcSEcCtD
Varenicline—Feeling abnormal—Fluorouracil—colon cancer	0.00126	0.00126	CcSEcCtD
Varenicline—Muscle spasms—Capecitabine—colon cancer	0.00125	0.00125	CcSEcCtD
Varenicline—Infestation NOS—Methotrexate—colon cancer	0.00124	0.00124	CcSEcCtD
Varenicline—Infestation—Methotrexate—colon cancer	0.00124	0.00124	CcSEcCtD
Varenicline—Depression—Methotrexate—colon cancer	0.00124	0.00124	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00123	0.00123	CcSEcCtD
Varenicline—Vision blurred—Capecitabine—colon cancer	0.00123	0.00123	CcSEcCtD
Varenicline—Tremor—Capecitabine—colon cancer	0.00122	0.00122	CcSEcCtD
Varenicline—Stomatitis—Methotrexate—colon cancer	0.00121	0.00121	CcSEcCtD
Varenicline—Ill-defined disorder—Capecitabine—colon cancer	0.00121	0.00121	CcSEcCtD
Varenicline—Urticaria—Fluorouracil—colon cancer	0.00121	0.00121	CcSEcCtD
Varenicline—Conjunctivitis—Methotrexate—colon cancer	0.00121	0.00121	CcSEcCtD
Varenicline—Anaemia—Capecitabine—colon cancer	0.00121	0.00121	CcSEcCtD
Varenicline—Body temperature increased—Fluorouracil—colon cancer	0.00121	0.00121	CcSEcCtD
Varenicline—Hypersensitivity—Vincristine—colon cancer	0.0012	0.0012	CcSEcCtD
Varenicline—Malaise—Capecitabine—colon cancer	0.00118	0.00118	CcSEcCtD
Varenicline—Hepatobiliary disease—Methotrexate—colon cancer	0.00118	0.00118	CcSEcCtD
Varenicline—Epistaxis—Methotrexate—colon cancer	0.00117	0.00117	CcSEcCtD
Varenicline—Vertigo—Capecitabine—colon cancer	0.00117	0.00117	CcSEcCtD
Varenicline—Hypersensitivity—Irinotecan—colon cancer	0.00117	0.00117	CcSEcCtD
Varenicline—Asthenia—Vincristine—colon cancer	0.00117	0.00117	CcSEcCtD
Varenicline—Syncope—Capecitabine—colon cancer	0.00117	0.00117	CcSEcCtD
Varenicline—Palpitations—Capecitabine—colon cancer	0.00115	0.00115	CcSEcCtD
Varenicline—Loss of consciousness—Capecitabine—colon cancer	0.00115	0.00115	CcSEcCtD
Varenicline—Asthenia—Irinotecan—colon cancer	0.00114	0.00114	CcSEcCtD
Varenicline—Cough—Capecitabine—colon cancer	0.00114	0.00114	CcSEcCtD
Varenicline—Hypertension—Capecitabine—colon cancer	0.00113	0.00113	CcSEcCtD
Varenicline—Hypersensitivity—Fluorouracil—colon cancer	0.00112	0.00112	CcSEcCtD
Varenicline—Diarrhoea—Vincristine—colon cancer	0.00112	0.00112	CcSEcCtD
Varenicline—Chest pain—Capecitabine—colon cancer	0.00111	0.00111	CcSEcCtD
Varenicline—Myalgia—Capecitabine—colon cancer	0.00111	0.00111	CcSEcCtD
Varenicline—Arthralgia—Capecitabine—colon cancer	0.00111	0.00111	CcSEcCtD
Varenicline—Anxiety—Capecitabine—colon cancer	0.00111	0.00111	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.0011	0.0011	CcSEcCtD
Varenicline—Urinary tract disorder—Methotrexate—colon cancer	0.0011	0.0011	CcSEcCtD
Varenicline—Discomfort—Capecitabine—colon cancer	0.0011	0.0011	CcSEcCtD
Varenicline—Urethral disorder—Methotrexate—colon cancer	0.00109	0.00109	CcSEcCtD
Varenicline—Diarrhoea—Irinotecan—colon cancer	0.00109	0.00109	CcSEcCtD
Varenicline—Dry mouth—Capecitabine—colon cancer	0.00109	0.00109	CcSEcCtD
Varenicline—Dizziness—Vincristine—colon cancer	0.00108	0.00108	CcSEcCtD
Varenicline—Pruritus—Fluorouracil—colon cancer	0.00108	0.00108	CcSEcCtD
Varenicline—Visual impairment—Methotrexate—colon cancer	0.00108	0.00108	CcSEcCtD
Varenicline—Oedema—Capecitabine—colon cancer	0.00107	0.00107	CcSEcCtD
Varenicline—Infection—Capecitabine—colon cancer	0.00106	0.00106	CcSEcCtD
Varenicline—Erythema multiforme—Methotrexate—colon cancer	0.00106	0.00106	CcSEcCtD
Varenicline—Dizziness—Irinotecan—colon cancer	0.00105	0.00105	CcSEcCtD
Varenicline—Shock—Capecitabine—colon cancer	0.00105	0.00105	CcSEcCtD
Varenicline—Nervous system disorder—Capecitabine—colon cancer	0.00104	0.00104	CcSEcCtD
Varenicline—Eye disorder—Methotrexate—colon cancer	0.00104	0.00104	CcSEcCtD
Varenicline—Diarrhoea—Fluorouracil—colon cancer	0.00104	0.00104	CcSEcCtD
Varenicline—Thrombocytopenia—Capecitabine—colon cancer	0.00104	0.00104	CcSEcCtD
Varenicline—Tinnitus—Methotrexate—colon cancer	0.00104	0.00104	CcSEcCtD
Varenicline—Tachycardia—Capecitabine—colon cancer	0.00104	0.00104	CcSEcCtD
Varenicline—Vomiting—Vincristine—colon cancer	0.00104	0.00104	CcSEcCtD
Varenicline—Cardiac disorder—Methotrexate—colon cancer	0.00104	0.00104	CcSEcCtD
Varenicline—Skin disorder—Capecitabine—colon cancer	0.00103	0.00103	CcSEcCtD
Varenicline—Rash—Vincristine—colon cancer	0.00103	0.00103	CcSEcCtD
Varenicline—Hyperhidrosis—Capecitabine—colon cancer	0.00103	0.00103	CcSEcCtD
Varenicline—Dermatitis—Vincristine—colon cancer	0.00103	0.00103	CcSEcCtD
Varenicline—Headache—Vincristine—colon cancer	0.00102	0.00102	CcSEcCtD
Varenicline—Anorexia—Capecitabine—colon cancer	0.00102	0.00102	CcSEcCtD
Varenicline—Angiopathy—Methotrexate—colon cancer	0.00101	0.00101	CcSEcCtD
Varenicline—Vomiting—Irinotecan—colon cancer	0.00101	0.00101	CcSEcCtD
Varenicline—Immune system disorder—Methotrexate—colon cancer	0.00101	0.00101	CcSEcCtD
Varenicline—Dizziness—Fluorouracil—colon cancer	0.00101	0.00101	CcSEcCtD
Varenicline—Mediastinal disorder—Methotrexate—colon cancer	0.00101	0.00101	CcSEcCtD
Varenicline—Rash—Irinotecan—colon cancer	0.001	0.001	CcSEcCtD
Varenicline—Dermatitis—Irinotecan—colon cancer	0.001	0.001	CcSEcCtD
Varenicline—Chills—Methotrexate—colon cancer	0.001	0.001	CcSEcCtD
Varenicline—Headache—Irinotecan—colon cancer	0.000997	0.000997	CcSEcCtD
Varenicline—Hypotension—Capecitabine—colon cancer	0.000995	0.000995	CcSEcCtD
Varenicline—Mental disorder—Methotrexate—colon cancer	0.000978	0.000978	CcSEcCtD
Varenicline—Erythema—Methotrexate—colon cancer	0.000972	0.000972	CcSEcCtD
Varenicline—Malnutrition—Methotrexate—colon cancer	0.000972	0.000972	CcSEcCtD
Varenicline—Nausea—Vincristine—colon cancer	0.000971	0.000971	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000971	0.000971	CcSEcCtD
Varenicline—Vomiting—Fluorouracil—colon cancer	0.000969	0.000969	CcSEcCtD
Varenicline—Insomnia—Capecitabine—colon cancer	0.000964	0.000964	CcSEcCtD
Varenicline—Rash—Fluorouracil—colon cancer	0.000961	0.000961	CcSEcCtD
Varenicline—Dermatitis—Fluorouracil—colon cancer	0.00096	0.00096	CcSEcCtD
Varenicline—Headache—Fluorouracil—colon cancer	0.000955	0.000955	CcSEcCtD
Varenicline—Dysgeusia—Methotrexate—colon cancer	0.000952	0.000952	CcSEcCtD
Varenicline—Dyspnoea—Capecitabine—colon cancer	0.00095	0.00095	CcSEcCtD
Varenicline—Nausea—Irinotecan—colon cancer	0.000945	0.000945	CcSEcCtD
Varenicline—Back pain—Methotrexate—colon cancer	0.00094	0.00094	CcSEcCtD
Varenicline—Dyspepsia—Capecitabine—colon cancer	0.000938	0.000938	CcSEcCtD
Varenicline—Decreased appetite—Capecitabine—colon cancer	0.000926	0.000926	CcSEcCtD
Varenicline—Gastrointestinal disorder—Capecitabine—colon cancer	0.00092	0.00092	CcSEcCtD
Varenicline—Fatigue—Capecitabine—colon cancer	0.000918	0.000918	CcSEcCtD
Varenicline—Vision blurred—Methotrexate—colon cancer	0.000916	0.000916	CcSEcCtD
Varenicline—Pain—Capecitabine—colon cancer	0.000911	0.000911	CcSEcCtD
Varenicline—Constipation—Capecitabine—colon cancer	0.000911	0.000911	CcSEcCtD
Varenicline—Nausea—Fluorouracil—colon cancer	0.000906	0.000906	CcSEcCtD
Varenicline—Ill-defined disorder—Methotrexate—colon cancer	0.000902	0.000902	CcSEcCtD
Varenicline—Anaemia—Methotrexate—colon cancer	0.000898	0.000898	CcSEcCtD
Varenicline—Feeling abnormal—Capecitabine—colon cancer	0.000878	0.000878	CcSEcCtD
Varenicline—Malaise—Methotrexate—colon cancer	0.000876	0.000876	CcSEcCtD
Varenicline—Vertigo—Methotrexate—colon cancer	0.000873	0.000873	CcSEcCtD
Varenicline—Gastrointestinal pain—Capecitabine—colon cancer	0.000871	0.000871	CcSEcCtD
Varenicline—Cough—Methotrexate—colon cancer	0.000848	0.000848	CcSEcCtD
Varenicline—Urticaria—Capecitabine—colon cancer	0.000846	0.000846	CcSEcCtD
Varenicline—Abdominal pain—Capecitabine—colon cancer	0.000842	0.000842	CcSEcCtD
Varenicline—Body temperature increased—Capecitabine—colon cancer	0.000842	0.000842	CcSEcCtD
Varenicline—Convulsion—Methotrexate—colon cancer	0.000842	0.000842	CcSEcCtD
Varenicline—Arthralgia—Methotrexate—colon cancer	0.000827	0.000827	CcSEcCtD
Varenicline—Chest pain—Methotrexate—colon cancer	0.000827	0.000827	CcSEcCtD
Varenicline—Myalgia—Methotrexate—colon cancer	0.000827	0.000827	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000822	0.000822	CcSEcCtD
Varenicline—Discomfort—Methotrexate—colon cancer	0.000817	0.000817	CcSEcCtD
Varenicline—Infection—Methotrexate—colon cancer	0.000788	0.000788	CcSEcCtD
Varenicline—Hypersensitivity—Capecitabine—colon cancer	0.000785	0.000785	CcSEcCtD
Varenicline—Nervous system disorder—Methotrexate—colon cancer	0.000778	0.000778	CcSEcCtD
Varenicline—Thrombocytopenia—Methotrexate—colon cancer	0.000776	0.000776	CcSEcCtD
Varenicline—Skin disorder—Methotrexate—colon cancer	0.00077	0.00077	CcSEcCtD
Varenicline—Hyperhidrosis—Methotrexate—colon cancer	0.000767	0.000767	CcSEcCtD
Varenicline—Asthenia—Capecitabine—colon cancer	0.000764	0.000764	CcSEcCtD
Varenicline—Anorexia—Methotrexate—colon cancer	0.000756	0.000756	CcSEcCtD
Varenicline—Pruritus—Capecitabine—colon cancer	0.000754	0.000754	CcSEcCtD
Varenicline—Hypotension—Methotrexate—colon cancer	0.000741	0.000741	CcSEcCtD
Varenicline—Diarrhoea—Capecitabine—colon cancer	0.000729	0.000729	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000723	0.000723	CcSEcCtD
Varenicline—Insomnia—Methotrexate—colon cancer	0.000717	0.000717	CcSEcCtD
Varenicline—Dyspnoea—Methotrexate—colon cancer	0.000707	0.000707	CcSEcCtD
Varenicline—Somnolence—Methotrexate—colon cancer	0.000705	0.000705	CcSEcCtD
Varenicline—Dizziness—Capecitabine—colon cancer	0.000704	0.000704	CcSEcCtD
Varenicline—Dyspepsia—Methotrexate—colon cancer	0.000698	0.000698	CcSEcCtD
Varenicline—Decreased appetite—Methotrexate—colon cancer	0.000689	0.000689	CcSEcCtD
Varenicline—Gastrointestinal disorder—Methotrexate—colon cancer	0.000685	0.000685	CcSEcCtD
Varenicline—Fatigue—Methotrexate—colon cancer	0.000684	0.000684	CcSEcCtD
Varenicline—Pain—Methotrexate—colon cancer	0.000678	0.000678	CcSEcCtD
Varenicline—Vomiting—Capecitabine—colon cancer	0.000677	0.000677	CcSEcCtD
Varenicline—Rash—Capecitabine—colon cancer	0.000672	0.000672	CcSEcCtD
Varenicline—Dermatitis—Capecitabine—colon cancer	0.000671	0.000671	CcSEcCtD
Varenicline—Headache—Capecitabine—colon cancer	0.000667	0.000667	CcSEcCtD
Varenicline—Feeling abnormal—Methotrexate—colon cancer	0.000654	0.000654	CcSEcCtD
Varenicline—Gastrointestinal pain—Methotrexate—colon cancer	0.000649	0.000649	CcSEcCtD
Varenicline—Nausea—Capecitabine—colon cancer	0.000633	0.000633	CcSEcCtD
Varenicline—Urticaria—Methotrexate—colon cancer	0.00063	0.00063	CcSEcCtD
Varenicline—Abdominal pain—Methotrexate—colon cancer	0.000627	0.000627	CcSEcCtD
Varenicline—Body temperature increased—Methotrexate—colon cancer	0.000627	0.000627	CcSEcCtD
Varenicline—Hypersensitivity—Methotrexate—colon cancer	0.000584	0.000584	CcSEcCtD
Varenicline—Asthenia—Methotrexate—colon cancer	0.000569	0.000569	CcSEcCtD
Varenicline—Pruritus—Methotrexate—colon cancer	0.000561	0.000561	CcSEcCtD
Varenicline—Diarrhoea—Methotrexate—colon cancer	0.000543	0.000543	CcSEcCtD
Varenicline—Dizziness—Methotrexate—colon cancer	0.000524	0.000524	CcSEcCtD
Varenicline—Vomiting—Methotrexate—colon cancer	0.000504	0.000504	CcSEcCtD
Varenicline—Rash—Methotrexate—colon cancer	0.0005	0.0005	CcSEcCtD
Varenicline—Dermatitis—Methotrexate—colon cancer	0.0005	0.0005	CcSEcCtD
Varenicline—Headache—Methotrexate—colon cancer	0.000497	0.000497	CcSEcCtD
Varenicline—Nausea—Methotrexate—colon cancer	0.000471	0.000471	CcSEcCtD
